GlassScriptPhysician profile
Ratna Singh
NPI 1154618957
$6,099.95
in general payments reported to CMS, 2019-2025
34 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $185 · 2021: $199 · 2022: $1,119 · 2023: $699 · 2024: $2,485 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,139 · Travel and Lodging: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,139.25 |
| Travel and Lodging | $1,203.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $2,751.00 | 2019-2025 | Azur Cx Detachable, Metacross Otw, Navicross |
| Cook Medical LLC | $703.69 | 2019-2025 | Zilver Ptx, Zenith Spiral-Z, Advance |
| Shockwave Medical, INC | $439.91 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Organogenesis INC. | $405.10 | 2022-2025 | Apligraf, Puraply Am, Puraply Wound Matrix |
| Kerecis Limited | $251.19 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Bard Peripheral Vascular, INC. | $172.52 | 2025 | Rotarexs 6 F X 135 Cm |
| Stryker Corporation | $157.14 | 2025 | Limflow System |
| Bolton Medical INC | $136.46 | 2022 | |
| Smith+Nephew, INC. | $127.38 | 2022-2025 | Collagenase Santyl, Regranex |
| Resmed Corp | $110.96 | 2022-2023 | |
| Boston Scientific Corporation | $109.47 | 2021-2025 | General - Catheters |
| Solventum Corporation | $69.25 | 2024-2025 | Activ.A.C., Prevena, V.A.C.Ulta |
| Atricure, INC. | $62.18 | 2022 | |
| Medtronic, INC. | $58.94 | 2021-2023 | Heli-Fx Endoanchor System, Endurant Iis |
| Philips North America LLC | $45.67 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $43.48 | 2024 | Bridion |
| Tactile Systems Technology INC | $43.43 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Advanced Oxygen Therapy INC. | $40.68 | 2025 | Topical Oxygen Chamber For Extremities |
| Astrazeneca Pharmaceuticals LP | $37.52 | 2023-2024 | Farxiga |
| Bioventus LLC | $32.99 | 2023 | |
| Imperative Care, INC | $31.79 | 2025 | Prodigy Catheter |
| Integra Lifesciences Corporation | $29.71 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.74 | 2023 | Jardiance |
| Lemaitre Vascular, INC. | $25.53 | 2024 | Artegraft Vascular Graft |
| Imbed Biosciences INC. | $25.31 | 2022 | |
| Convatec INC. | $24.39 | 2025 | |
| Endologix LLC | $23.46 | 2021 | |
| Sirtex Medical INC | $19.63 | 2025 | Sir-Spheres Microspheres |
| Kci USA, INC. | $18.67 | 2023 | 3m Coban, Promogran Prisma, Activ.A.C. |
| Mimedx Group, INC. | $16.85 | 2024 | |
| Ethicon US, LLC | $15.64 | 2025 | Prolene, Evarrest, Ethicon |
| Electromed, INC. | $15.43 | 2019 | |
| Acera Surgical, INC. | $14.04 | 2025 | Restrata Wound Matrix |
| Reprise Biomedical, INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ratna Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.